More Ways to Connect
  LinkedIn Twitter YouTube Instagram
  RSS
Search
Image Gallery







UC researchers Rita Alloway, PharmD; E. Steve Woodle, MD; and Adele Shields, PharmD, will lead the multicenter BEST study.  
Rita Alloway, PharmD; E. Steve Woodle, MD; and Adele Shields, PharmD
UC researchers Rita Alloway, PharmD; E. Steve Woodle, MD; and Adele Shields, PhD, will lead the multicenter BEST study, a $5.2 million national trial studying removal of both corticosteroids and common immunosuppression treatments from the post-transplant drug regimen for kidney transplant patients.

Photo Date: 11/28/12


PHOTO CREDIT: This photo is the property of the University of Cincinnati. Use of this photo requires credit to the University of Cincinnati. If you have any questions, please contact Academic Health Center public relations at (513) 558-4553 or uchealthnews@uc.edu.

 
THIS IMAGE IN THE NEWS
keywords: kidney transplantation, transplant, E. Steve Woodle, Adele Shields, Rita Alloway, surgery, transplant clinical research, internal medicine, BEST, belatacept, CNI, immunosuppression
UC Researchers Find Alternate Drug Therapy Lowers Antibodies . 12/23/14
UC Leading First Multicenter Trial Studying Steroid and CNI Immunosuppression Withdrawal Post-Transplant. 11/28/12
 back to list | back to top